Astrana Health (ASTH) 2020年年度报告「NASDAQ」.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K(Mark One)?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2020OR?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF193

2、4for the transition period from _ to _.Commission file number:001-37392Apollo Medical Holdings,Inc.(Exact name of registrant as specified in its charter)Delaware95-4472349(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)1668 S.Garfield Avenue,2nd Floor,A

3、lhambra,California 91801(Address of principal executive offices,including zip code)Registrants telephone number,including area code:(626)282-0288Securities registered pursuant to Section 12(b)of the Act:Title of Each Class Trading Symbol Name of Each Exchange on Which RegisteredCommon Stock,$0.001 p

4、ar value per share AMEH Nasdaq Capital MarketSecurities registered pursuant to Section 12(g)of the Act:None(Title of class)Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes?No?Indicate by check mark if the registrant is not requ

5、ired to file reports pursuant to Section 13 or 15(d)of the Exchange Act.Yes?No?Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or forsuch shorter period that the reg

6、istrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes?No?Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of